# Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients

> **NCT04501965** · PHASE2 · UNKNOWN · sponsor: **Institute for Research and Development of Medicinal and Food Plants of Guinea** · enrollment: 231 (actual)

## Conditions studied

- Covid19

## Interventions

- **COMBINATION_PRODUCT:** Hydroxychloroquine/Azithromycine
- **COMBINATION_PRODUCT:** Quinquina-Stevia/Azythromycin
- **COMBINATION_PRODUCT:** 4Plants/Azythromycin

## Key facts

- **NCT ID:** NCT04501965
- **Lead sponsor:** Institute for Research and Development of Medicinal and Food Plants of Guinea
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2020-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04501965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04501965, "Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04501965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*